Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara A Fielding

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism|October 23, 2022
Effect of Dapagliflozin on Cardiac Function and Metabolic and Hormonal Responses to ExerciseRoselle A Herring, Iain Parsons, Fariba Shojaee-Moradie, et al.
Diabetes|April 28, 2005
Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gammaUlf Risérus, Garry D Tan, Barbara A Fielding, et al.
The British Journal of Nutrition|September 18, 2003
Long-term monounsaturated fatty acid diets reduce platelet aggregation in healthy young subjectsRuth D Smith, Colette N M Kelly, Barbara A Fielding, et al.
The American Journal of Clinical Nutrition|March 6, 2021
Palmitic acid-rich oils with and without interesterification lower postprandial lipemia and increase atherogenic lipoproteins compared with a MUFA-rich oil: A randomized controlled trialCharlotte E Mills, Scott V Harding, Mariam Bapir, et al.
Diabetes Care|October 17, 2013
Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitroHenrike Sell, Matthias Blüher, Nora Klöting, et al.
Diabetes|October 15, 2010
Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition?Siobhán E McQuaid, Leanne Hodson, Matthew J Neville, et al.
Diabetes Care|July 10, 2020
Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 DiabetesRoselle A Herring, Fariba Shojaee-Moradie, Robert Garesse, et al.
Diabetes Care|February 20, 2021
Response to Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136Roselle A Herring, Fariba Shojaee-Moradie, Robert Garesse, et al.
Diabetes Care|March 21, 2022
The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested Fatty Acids to Ketones in Type 2 DiabetesRoselle A Herring, Fariba Shojaee-Moradie, Mary Stevenage, et al.
The American Journal of Clinical Nutrition|August 7, 2024
Variation of LDL cholesterol in response to the replacement of saturated with unsaturated fatty acids: a nonrandomized, sequential dietary intervention; the Reading, Imperial, Surrey, Saturated fat Cholesterol Intervention ("RISSCI"-1) studyAthanasios Koutsos, Bruce A Griffin, Rona Antoni, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|October 23, 2022
Effect of Dapagliflozin on Cardiac Function and Metabolic and Hormonal Responses to ExerciseRoselle A Herring, Iain Parsons, Fariba Shojaee-Moradie, et al.
Diabetes|April 28, 2005
Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gammaUlf Risérus, Garry D Tan, Barbara A Fielding, et al.
The British Journal of Nutrition|September 18, 2003
Long-term monounsaturated fatty acid diets reduce platelet aggregation in healthy young subjectsRuth D Smith, Colette N M Kelly, Barbara A Fielding, et al.
The American Journal of Clinical Nutrition|March 6, 2021
Palmitic acid-rich oils with and without interesterification lower postprandial lipemia and increase atherogenic lipoproteins compared with a MUFA-rich oil: A randomized controlled trialCharlotte E Mills, Scott V Harding, Mariam Bapir, et al.
Diabetes Care|October 17, 2013
Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitroHenrike Sell, Matthias Blüher, Nora Klöting, et al.
Diabetes|October 15, 2010
Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition?Siobhán E McQuaid, Leanne Hodson, Matthew J Neville, et al.
Diabetes Care|July 10, 2020
Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 DiabetesRoselle A Herring, Fariba Shojaee-Moradie, Robert Garesse, et al.
Diabetes Care|February 20, 2021
Response to Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136Roselle A Herring, Fariba Shojaee-Moradie, Robert Garesse, et al.
Diabetes Care|March 21, 2022
The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested Fatty Acids to Ketones in Type 2 DiabetesRoselle A Herring, Fariba Shojaee-Moradie, Mary Stevenage, et al.
The American Journal of Clinical Nutrition|August 7, 2024
Variation of LDL cholesterol in response to the replacement of saturated with unsaturated fatty acids: a nonrandomized, sequential dietary intervention; the Reading, Imperial, Surrey, Saturated fat Cholesterol Intervention ("RISSCI"-1) studyAthanasios Koutsos, Bruce A Griffin, Rona Antoni, et al.
Pageof 9